help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ching, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ching, M.

Endocrinology, Vol 112, 2209-2211, Copyright © 1983 by Endocrine Society


ARTICLES

Morphine suppresses the proestrous surge of GnrH in pituitary portal plasma of rats

M Ching

Virgin proestrous rats were acutely treated with 2 doses of morphine sulfate (MS) (5-8 and 40 mg/kg BW) or naloxone HCl (NH) (10 mg/kg BW) co-administered with the high dose of MS, and the pituitary portal plasma concentrations of gonadotropin releasing hormone (GnRH) were compared with those of untreated proestrous (PE) and diestrous (DE) control animals. LH and FSH were measured in systemic plasma obtained by venipuncture just prior to the collection of portal blood. Both doses of MS severely diminished the PE surges of LH and FSH, but NH reversed the effect of MS and restored the circulating gonadotropins to PE levels. However, only PE rats treated with the high dose of MS exhibited significantly reduced GnRH concentrations in portal plasma. This suggests that the reduction of gonadotropin concentrations is not due merely to reduced GnRH secretion by the hypothalamus but may involve other mechanism(s) as well. However, in rats given the high dose of MS the severe reduction in pituitary gonadotropin secretion is attributable in large part to the corresponding decrease in hypothalamic GnRH release, since NH restored the GnRH and LH/FSH plasma concentrations to PE levels.


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
R. M. Sapolsky, L. M. Romero, and A. U. Munck
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions
Endocr. Rev., February 1, 2000; 21(1): 55 - 89.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. K. Bhat, V. B. Mahesh, L. Ping, L. Chorich, V. T. Wiedmeier, and D. W. Brann
Opioid-Glutamate-Nitric Oxide Connection in the Regulation of Luteinizing Hormone Secretion in the Rat
Endocrinology, March 1, 1998; 139(3): 955 - 960.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. I. Sannella and S. L. Petersen
Dual Label in Situ Hybridization Studies Provide Evidence that Luteinizing Hormone-Releasing Hormone Neurons Do Not Synthesize Messenger Ribonucleic Acid for {micro}, {kappa}, or {delta} Opiate Receptors
Endocrinology, April 1, 1997; 138(4): 1667 - 1672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1983 by The Endocrine Society